Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin exchange balances see daily outflow but weekly inflow; US trading volume spikes 357%

Market News
19 Oct 2026
Tokenpost
View Source
Neutral
Bitcoin exchange balances see daily outflow but weekly inflow; US trading volume spikes 357%

Bitcoin balances on major exchanges showed a daily net outflow of 1,860.51 BTC but maintained a weekly net inflow of 7,348.21 BTC, indicating mixed short- and medium-term trends. Over the past 30 days, exchanges experienced a net outflow of 33,358.25 BTC, suggesting a medium-term decline in exchange-held Bitcoin. Coinbase Pro holds the largest balance with 837,971.85 BTC but saw daily and weekly outflows, while Binance, with the second-largest balance, had a significant daily outflow but a strong weekly inflow. Binance's BTCUSDT trading volume surged during US hours to $562.11 million on October 18, a 357% increase from the previous day, leading global session activity. This data highlights shifting investor behavior and increased trading activity during US market hours.

The story on Bitcoin liquidity and exchange flows is complemented by Pluang's market snapshot as of Oct 19, 2026 18:21 WIB: among 50 major cryptocurrencies priced on Pluang, 23 rose and 25 fell today. Notable movers include FTM (Fantom) at Rp11.382 with a -2.05% change and a typical hold time of 88 days, THETA (Theta Network) at Rp3.369 with a -2.04% change and 78 days hold time, and AXS (Axie Infinity) at Rp18.020 with a -1.83% change, 100% buy order activity, and a typical hold time of 62 days.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
1 hour ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
1 hour ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
1 hour ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
1 hour ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App